Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging

Journal of Nuclear Cardiology

Volumn 15, Issue 5, 2008, Pages 631-637

  Morishima, Itsuro ^a   Sone, Takahito ^a   Tsuboi, Hideyuki ^a   Mukawa, Hiroaki ^a   Uesugi, Michitaka ^a   Morikawa, Shuji ^a   Takagi, Kensuke ^a   Niwa, Toru ^a   Morita, Yasuhiro ^b   Murakami, Ryuichiro ^b   Numaguchi, Yasushi ^c   Murohara, Toyoaki ^b   Okumura, Kenji ^c  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

defect volume; MADIT II; myocardial perfusion single photon emission computed tomography imaging; Ventricular tachyarrhythmia

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GATED IMAGING; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ROC CURVE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 50149094235     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2008.03.009     Document Type: Article

References (22)

1. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Bloomfield D.M., Bigger J.T., Steinman R.C., Namerow P.B., Parides M.K., Curtis A.B., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
4. Zwanziger J., Hall W.J., Dick A.W., Zhao H., Mushlin A.I., Hahn R.M., et al. The cost effectiveness of implantable cardioverter-defibrillators: Results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol 47 (2006) 2310-2318
5. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation 85 (1992) I50-I56
6. Bogun F., Good E., Reich S., Elmouchi D., Igic P., Lemola K., et al. Isolated potentials during sinus rhythm and pace-mapping within scars as guides for ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol 47 (2006) 2013-2019
7. Germano G., Erel J., Lewin H., Kavanagh P.B., and Berman D.S. Automatic quantitation of regional myocardial wall motion and thickening from gated technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 30 (1997) 1360-1367
8. Bigger Jr. J.T., Fleiss J.L., Kleiger R., Miller J.P., and Rolnitzky L.M. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69 (1984) 250-258
9. Stecker E.C., Vickers C., Waltz J., Socoteanu C., John B.T., Mariani R., et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: Two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 47 (2006) 1161-1166
10. Pascale P., Taffe P., Regamey C., Kappenberger L., and Fromer M. Reduced ejection fraction after myocardial infarction: Is it sufficient to justify implantation of a defibrillator?. Chest 128 (2005) 2626-2632
11. Roes S.D., Kelle S., Kaandorp T.A.M., Kokocinski T., Poldermans D., Lamb H.J., et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 100 (2007) 930-936
12. Baghdasarian S.B., and Heller G.V. The role of myocardial perfusion imaging in the diagnosis of patients with coronary artery disease: Developments over the past year. Curr Opin Cardiol 20 (2005) 369-374
13. Currie G.M., and Wheat J.M. Gated myocardial perfusion SPECT. [letter]. J Nucl Med Technol 33 (2005) 243
14. Shaw L.J., Hendel R., Borges-Neto S., Lauer M.S., Alazraki N., Burnette J., et al. Prognostic value of normal exercise and adenosine 99mTc-tetrofosmin SPECT imaging: Results from the multicenter registry of 4,728 patients. J Nucl Med 44 (2003) 134-139
15. Pitman A. Myocardial perfusion imaging-a validated and mature cardiac imaging modality. Aust Fam Physician 35 (2006) 288-292
16. Petix N.R., Sestini S., Marcucci G., Coppola A., Arena A., Nassi F., et al. Can the reversible regional wall motion abnormalities on stress gated Tc-99m sestamibi SPECT predict a future cardiac event?. J Nucl Cardiol 12 (2005) 20-31
17. Brindis R.G., Douglas P.S., Hendel R.C., Peterson E.D., Wolk M.J., Allen J.M., et al. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol 46 (2005) 1587-1605
18. Sharir T., Germano G., Kavanagh P.B., Lai S., Cohen I., Lewin H.C., et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100 (1999) 1035-1042
19. Iskandrian A.S., Heo J., Lemlek J., Ogilby J.D., Untereker W.J., Iskandrian B., et al. Identification of high-risk patients with left main and three-vessel coronary artery disease by adenosine-single photon emission computed tomographic thallium imaging. Am Heart J 125 (1993) 1130-1135
20. van der Burg A.E., Bax J.J., Boersma E., Pauwels E.K., van der Wall E.E., and Schalij M.J. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. Circulation 108 (2003) 1954-1959
21. de Bakker J.M., van Capelle F.J., Janse M.J., Wilde A.A., Coronel R., Becker A.E., et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: Electrophysiologic and anatomic correlation. Circulation 77 (1988) 589-606
22. Tejima T., Sakurada H., Okazaki H., Motomiya T., and Hiraoka M. Significance of abnormal root mean square voltages in signal averaged electrocardiogram as a reliable predictor of sustained ventricular tachycardia. J Electrocardiol 31 (1998) 362-366